Structural Dynamics of Insulin Receptor and Transmembrane Signaling

Biochemistry

Volumn 54, Issue 36, 2015, Pages 5523-5532

  Tatulian, Suren A ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BINDING SITES; COVALENT BONDS; ENZYME ACTIVITY; ENZYMES; METABOLISM; PHOSPHORYLATION; SIGNALING; STRUCTURAL DYNAMICS; X RAY CRYSTALLOGRAPHY;

COMPARATIVE ASSESSMENT; CRYSTALLOGRAPHIC STUDIES; CYTOPLASMIC TYROSINE KINASE; PROTEIN PHOSPHORYLATION; RATIONAL DRUG DESIGNS; STRUCTURAL TRANSFORMATION; STRUCTURE-FUNCTION RELATIONSHIP; TRANS-MEMBRANE SIGNALING;

INSULIN;

INSULIN; INSULIN GROWTH FACTOR RECEPTOR 1; INSULIN RECEPTOR; INSULIN RECEPTOR RELATED RECEPTOR; MEMBRANE PROTEIN; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG; INSULIN RECEPTOR-RELATED RECEPTOR; PROTEIN SUBUNIT; SOMATOMEDIN C RECEPTOR;

ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; INSULIN BINDING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNIT;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; MUTATION; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

EID: 84941622155     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00805     Document Type: Article

References (91)

1. Boura-Halfon, S. and Zick, Y. (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance Am. J. Physiol. Endocrinol. Metab. 296, E581-E591 10.1152/ajpendo.90437.2008
2. Rubin, B. R. and Bogan, J. S. (2009) Intracellular retention and insulin-stimulated mobilization of GLUT4 glucose transporters Vitam. Horm. 80, 155-192 10.1016/S0083-6729(08)00607-9
3. Tatoń, J., Czech, A., and Piatkiewicz, P. (2010) Insulin as the main regulator of cellular glucose utilization-aetiological aspects of insulin resistance Endokrynol. Polym. 61, 388-394
4. Xie, X., Gong, Z., Mansuy-Aubert, V., Zhou, Q. L., Tatulian, S. A., Sehrt, D., Gnad, F., Brill, L. M., Motamedchaboki, K., Chen, Y., Czech, M. P., Mann, M., Krüger, M., and Jiang, Z. Y. (2011) C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane Cell Metab. 14, 378-389 10.1016/j.cmet.2011.06.015
5. Ward, C. W., Menting, J. G., and Lawrence, M. C. (2013) The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation BioEssays 35, 945-954 10.1002/bies.201300065
6. Hubbard, S. R. (2013) The insulin receptor: both a prototypical and atypical receptor tyrosine kinase Cold Spring Harbor Perspect. Biol. 5, a008946 10.1101/cshperspect.a008946
7. Govers, R. (2014) Molecular mechanisms of GLUT4 regulation in adipocytes Diabetes Metab. 40, 400-410 10.1016/j.diabet.2014.01.005
8. Accili, D., Cama, A., Barbetti, F., Kadowaki, H., Kadowaki, T., and Taylor, S. I. (1992) Insulin resistance due to mutations of the insulin receptor gene: an overview J. Endocrinol. Invest. 15, 857-864 10.1007/BF03348820
9. Sesti, G., Federici, M., Lauro, D., Sbraccia, P., and Lauro, R. (2001) Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms Diabetes/Metab. Res. Rev. 17, 363-373 10.1002/dmrr.225
10. LeRoith, D. and Accili, D. (2008) Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes Nat. Clin. Pract. Endocrinol. Metab. 4, 164-172 10.1038/ncpendmet0729
11. Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W. A. (1994) Crystal structure of the tyrosine kinase domain of the human insulin receptor Nature 372, 746-754 10.1038/372746a0
12. Menting, J. G., Whittaker, J., Margetts, M. B., Whittaker, L. J., Kong, G. K., Smith, B. J., Watson, C. J., Záková, L., Kletvíková, E., Jiráček, J., Chan, S. J., Steiner, D. F., Dodson, G. G., Brzozowski, A. M., Weiss, M. A., Ward, C. W., and Lawrence, M. C. (2013) How insulin engages its primary binding site on the insulin receptor Nature 493, 241-245 10.1038/nature11781
13. Hubbard, S. R. (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog EMBO J. 16, 5572-5581 10.1093/emboj/16.18.5572
14. Wu, J. J. and Guidotti, G. (2002) Construction and characterization of a monomeric insulin receptor J. Biol. Chem. 277, 27809-27817 10.1074/jbc.M200367200
15. McKern, N. M., Lawrence, M. C., Streltsov, V. A., Lou, M. Z., Adams, T. E., Lovrecz, G. O., Elleman, T. C., Richards, K. M., Bentley, J. D., Pilling, P. A., Hoyne, P. A., Cartledge, K. A., Pham, T. M., Lewis, J. L., Sankovich, S. E., Stoichevska, V., Da Silva, E., Robinson, C. P., Frenkel, M. J., Sparrow, L. G., Fernley, R. T., Epa, V. C., and Ward, C. W. (2006) Structure of the insulin receptor ectodomain reveals a folded-over conformation Nature 443, 218-221 10.1038/nature05106
16. Smith, B. J., Huang, K., Kong, G., Chan, S. J., Nakagawa, S., Menting, J. G., Hu, S. Q., Whittaker, J., Steiner, D. F., Katsoyannis, P. G., Ward, C. W., Weiss, M. A., and Lawrence, M. C. (2010) Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists Proc. Natl. Acad. Sci. U. S. A. 107, 6771-6776 10.1073/pnas.1001813107
17. Menting, J. G., Yang, Y., Chan, S. J., Phillips, N. B., Smith, B. J., Whittaker, J., Wickramasinghe, N. P., Whittaker, L. J., Pandyarajan, V., Wan, Z. L., Yadav, S. P., Carroll, J. M., Strokes, N., Roberts, C. T., Jr., Ismail-Beigi, F., Milewski, W., Steiner, D. F., Chauhan, V. S., Ward, C. W., Weiss, M. A., and Lawrence, M. C. (2014) Protective hinge in insulin opens to enable its receptor engagement Proc. Natl. Acad. Sci. U. S. A. 111, E3395-E3404 10.1073/pnas.1412897111
18. Menting, J. G., Lawrence, C. F., Kong, G. K., Margetts, M. B., Ward, C. W., and Lawrence, M. C. (2015) Structural congruency of ligand binding to the insulin and insulin/type 1 insulin-like growth factor hybrid receptors Structure 23, 1271-1282 10.1016/j.str.2015.04.016
19. De Meyts, P. (2015) Insulin/receptor binding: The last piece of the puzzle?: What recent progress on the structure of the insulin/ receptor complex tells us (or not) about negative cooperativity and activation BioEssays 37, 389-397 10.1002/bies.201400190
20. Cabail, M. Z., Li, S., Lemmon, E., Bowen, M. E., Hubbard, S. R., and Miller, W. T. (2015) The insulin and IGF1 receptor kinase domains are functional dimers in the activated state Nat. Commun. 6, 6406 10.1038/ncomms7406
21. Schäffer, L. (1994) A model for insulin binding to the insulin receptor Eur. J. Biochem. 221, 1127-1132 10.1111/j.1432-1033.1994.tb18833.x
22. Lee, J., Pilch, P. F., Shoelson, S. E., and Scarlata, S. F. (1997) Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy Biochemistry 36, 2701-2708 10.1021/bi961815g
23. Thorsøe, K. S., Schlein, M., Steensgaard, D. B., Brandt, J., Schluckebier, G., and Naver, H. (2010) Kinetic evidence for the sequential association of insulin binding sites 1 and 2 to the insulin receptor and the influence of receptor isoform Biochemistry 49, 6234-6246 10.1021/bi1000118
24. Leto, D. and Saltiel, A. R. (2012) Regulation of glucose transport by insulin: traffic control of GLUT4 Nat. Rev. Mol. Cell Biol. 13, 383-396 10.1038/nrm3351
25. Taubes, G. (2009) Prosperitys plague Science 325, 256-260 10.1126/science.325-256
26. Fröjdö, S., Vidal, H., and Pirola, L. (2009) Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans Biochim. Biophys. Acta, Mol. Basis Dis. 1792, 83-92 10.1016/j.bbadis.2008.10.019
27. Lee, B. C. and Lee, J. (2014) Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance Biochim. Biophys. Acta, Mol. Basis Dis. 1842, 446-462 10.1016/j.bbadis.2013.05.017
28. Kim, B. and Feldman, E. L. (2015) Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome Exp. Mol. Med. 47, e149 10.1038/emm.2015.3
29. Lan, A., Qi, Y., and Du, J. (2014) Akt2 mediates TGF-β1-induced epithelial to mesenchymal transition by deactivating GSK3β/snail signaling pathway in renal tubular epithelial cells Cell. Physiol. Biochem. 34, 368-82 10.1159/000363006
30. Tilg, H. and Moschen, A. R. (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol. Metab. 19, 371-379 10.1016/j.tem.2008.08.005
31. Brown, A. E., Palsgaard, J., Borup, R., Avery, P., Gunn, D. A., De Meyts, P., Yeaman, S. J., and Walker, M. (2015) p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients Am. J. Physiol. Endocrinol. Metab. 308, E63-E70 10.1152/ajpendo.00115.2014
32. Olson, T. S., Bamberger, M. J., and Lane, M. D. (1998) Post-translational changes in tertiary and quaternary structures of the insulin proreceptor. Correlation with acquisition of function J. Biol. Chem. 263, 7342-7351
33. Lawrence, M. C., McKern, N. M., and Ward, C. W. (2007) Insulin receptor structure and its implications for the IGF-1 receptor Curr. Opin. Struct. Biol. 17, 699-705 10.1016/j.sbi.2007.07.007
34. Ward, C. W. and Lawrence, M. C. (2009) Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor BioEssays 31, 422-434 10.1002/bies.200800210
35. Sparrow, L. G., Lawrence, M. C., Gorman, J. J., Strike, P. M., Robinson, C. P., McKern, N. M., and Ward, C. W. (2008) N-linked glycans of the human insulin receptor and their distribution over the crystal structure Proteins: Struct., Funct., Genet. 71, 426-439 10.1002/prot.21768
36. Rentería, M. E., Gandhi, N. S., Vinuesa, P., Helmerhorst, E., and Mancera, R. L. (2008) A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information PLoS One 3, e3667 10.1371/journal.pone.0003667
37. Denley, A., Wallace, J. C., Cosgrove, L. J., and Forbes, B. E. (2003) The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review Horm. Metab. Res. 35, 778-785 10.1055/s-2004-814157
38. Whitten, A. E., Smith, B. J., Menting, J. G., Margetts, M. B., McKern, N. M., Lovrecz, G. O., Adams, T. E., Richards, K., Bentley, J. D., Trewhella, J., Ward, C. W., and Lawrence, M. C. (2009) Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change J. Mol. Biol. 394, 878-392 10.1016/j.jmb.2009.10.011
39. De Meyts, P. (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signaling Diabetologia 37 (Suppl. 2) S135-S148 10.1007/BF00400837
40. Flörke, R. R., Klein, H. W., and Reinauer, H. (1990) Structural requirements for signal transduction of the insulin receptor Eur. J. Biochem. 191, 473-482 10.1111/j.1432-1033.1990.tb19146.x
41. Flörke, R. R., Klein, H. W., and Reinauer, H. (1993) Differential insertion of insulin receptor complexes into Triton X-114 bilayer membranes. Evidence for a differential accessibility of the membrane-exposed receptor domain Eur. J. Biochem. 211, 241-247 10.1111/j.1432-1033.1993.tb19892.x
42. Flörke, R. R., Schnaith, K., Passlack, W., Wichert, M., Kuehn, L., Fabry, M., Federwisch, M., and Reinauer, H. (2001) Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors Biochem. J. 360, 189-198 10.1042/bj3600189
43. Li, S., Covino, N. D., Stein, E. G., Till, J. H., and Hubbard, S. R. (2003) Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor J. Biol. Chem. 278, 26007-26014 10.1074/jbc.M302425200
44. Kavran, J. M., McCabe, J. M., Byrne, P. O., Connacher, M. K., Wang, Z., Ramek, A., Sarabipour, S., Shan, Y., Shaw, D. E., Hristova, K., Cole, P. A., and Leahy, D. J. (2014) How IGF-1 activates its receptor eLife 3, e03772 10.7554/eLife.03772
45. Vashisth, H. and Abrams, C. F. (2010) Docking of insulin to a structurally equilibrated insulin receptor ectodomain Proteins: Struct., Funct., Genet. 78, 1531-1543 10.1002/prot.22670
46. Lee, J., Miyazaki, M., Romeo, G. R., and Shoelson, S. E. (2014) Insulin receptor activation with transmembrane domain ligands J. Biol. Chem. 289, 19769-19777 10.1074/jbc.M114.578641
47. Dodson, G. and Steiner, D. (1998) The role of assembly in insulins biosynthesis Curr. Opin. Struct. Biol. 8, 189-194 10.1016/S0959-440X(98)80037-7
48. Derewenda, U., Derewenda, Z., Dodson, G. G., Hubbard, R. E., and Korber, F. (1989) Molecular structure of insulin: the insulin monomer and its assembly Br. Med. Bull. 45, 4-18
49. Hua, Q. X., Xu, B., Huang, K., Hu, S. Q., Nakagawa, S., Jia, W., Wang, S., Whittaker, J., Katsoyannis, P. G., and Weiss, M. A. (2009) Enhancing the activity of a protein by stereospecific unfolding: conformational life cycle of insulin and its evolutionary origins J. Biol. Chem. 284, 14586-14596 10.1074/jbc.M900085200
50. Wan, Z. L., Huang, K., Hu, S. Q., Whittaker, J., and Weiss, M. A. (2008) The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostatic block to the TR transition J. Biol. Chem. 283, 21198-21210 10.1074/jbc.M800235200
51. Kiselyov, V. V., Versteyhe, S., Gauguin, L., and De Meyts, P. (2009) Harmonic oscillator model of the insulin and IGF1 receptors allosteric binding and activation Mol. Syst. Biol. 5, 243 10.1038/msb.2008.78
52. De Meyts, P., Ursø, B., Christoffersen, C. T., and Shymko, R. M. (1995) Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling Ann. N. Y. Acad. Sci. 766, 388-401 10.1111/j.1749-6632.1995.tb26688.x
53. De Meyts, P. and Whittaker, J. (2002) Structural biology of insulin and IGF1 receptors: implications for drug design Nat. Rev. Drug Discovery 1, 769-783 10.1038/nrd917
54. De Meyts, P. (2008) The insulin receptor: a prototype for dimeric, allosteric membrane receptors? Trends Biochem. Sci. 33, 376-384 10.1016/j.tibs.2008.06.003
55. Whittaker, J. and Whittaker, L. (2005) Characterization of the functional insulin binding epitopes of the full-length insulin receptor J. Biol. Chem. 280, 20932-20936 10.1074/jbc.M411320200
56. Whittaker, L., Hao, C., Fu, W., and Whittaker, J. (2008) High-affinity insulin binding: Insulin interacts with two receptor ligand binding sites Biochemistry 47, 12900-12909 10.1021/bi801693h
57. Whittaker, J., Whittaker, L. J., Roberts, C. T., Jr., Phillips, N. B., Ismail-Beigi, F., Lawrence, M. C., and Weiss, M. A. (2012) α-Helical element at the hormone-binding surface of the insulin receptor functions as a signaling element to activate its tyrosine kinase Proc. Natl. Acad. Sci. U. S. A. 109, 11166-11171 10.1073/pnas.1205681109
58. Inoue, G., Cheatham, B., Emkey, R., and Kahn, C. R. (1998) Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2 J. Biol. Chem. 273, 11548-11555 10.1074/jbc.273.19.11548
59. Jiang, Z. Y., Zhou, Q. L., Chatterjee, A., Feener, E. P., Myers, M. G., Jr., White, M. F., and King, G. L. (1999) Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells Diabetes 48, 1120-1130 10.2337/diabetes.48.5.1120
60. Hernández-Sánchez, C., Mansilla, A., de Pablo, F., and Zardoya, R. (2008) Evolution of the insulin receptor family and receptor isoform expression in vertebrates Mol. Biol. Evol. 25, 1043-1053 10.1093/molbev/msn036
61. Casa, A. J., Dearth, R. K., Litzenburger, B. C., Lee, A. V., and Cui, X. (2008) The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance Front. Biosci., Landmark Ed. 13, 3273-3287 10.2741/2925
62. Rieder, S., Michalski, C. W., Friess, H., and Kleeff, J. (2011) Insulin-like growth factor signaling as a therapeutic target in pancreatic cancer Anti-Cancer Agents Med. Chem. 11, 427-433 10.2174/187152011795677454
63. Trajkovic-Arsic, M., Kalideris, E., and Siveke, J. T. (2013) The role of insulin and IGF system in pancreatic cancer J. Mol. Endocrinol. 50, R67-R74 10.1530/JME-12-0259
64. Petrenko, A. G., Zozulya, S. A., Deyev, I. E., and Eladari, D. (2013) Insulin receptor-related receptor as an extracellular pH sensor involved in the regulation of acid-base balance Biochim. Biophys. Acta, Proteins Proteomics 1834, 2170-2175 10.1016/j.bbapap.2012.11.011
65. Slaaby, R. (2015) Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin Sci. Rep. 5, 7911 10.1038/srep07911
66. Gallagher, E. J. and LeRoith, D. (2010) The proliferating role of insulin and insulin-like growth factors in cancer Trends Endocrinol. Metab. 21, 610-618 10.1016/j.tem.2010.06.007
67. Singh, P., Alex, J. M., and Bast, F. (2014) Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer Med. Oncol. 31, 805 10.1007/s12032-013-0805-3
68. Brown, J., Jones, E. Y., and Forbes, B. E. (2009) Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure Trends Biochem. Sci. 34, 612-619 10.1016/j.tibs.2009.07.003
69. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y. (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity EMBO J. 5, 2503-2512
70. Adams, T. E., Epa, V. C., Garrett, T. P., and Ward, C. W. (2000) Structure and function of the type 1 insulin-like growth factor receptor Cell. Mol. Life Sci. 57, 1050-1093 10.1007/PL00000744
71. Ward, C. W., Garrett, T. P., McKern, N. M., Lou, M., Cosgrove, L. J., Sparrow, L. G., Frenkel, M. J., Hoyne, P. A., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Lawrence, L. J., and Tulloch, P. A. (2001) The three dimensional structure of the type I insulin-like growth factor receptor Mol. Pathol. 54, 125-132 10.1136/mp.54.3.125
72. Christoffersen, C. T., Bornfeldt, K. E., Rotella, C. M., Gonzales, N., Vissing, H., Shymko, R. M., ten Hoeve, J., Groffen, J., Heisterkamp, N., and De Meyts, P. (1994) Negative cooperativity in the insulin-like growth factor-I receptor and a chimeric IGF-I/insulin receptor Endocrinology 135, 472-475 10.1210/endo.135.1.8013387
73. Garrett, T. P., McKern, N. M., Lou, M., Frenkel, M. J., Bentley, J. D., Lovrecz, G. O., Elleman, T. C., Cosgrove, L. J., and Ward, C. W. (1998) Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor Nature 394, 395-399 10.1038/28668
74. Surinya, K. H., Forbes, B. E., Occhiodoro, F., Booker, G. W., Francis, G. L., Siddle, K., Wallace, J. C., and Cosgrove, L. J. (2007) An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors J. Biol. Chem. 283, 5355-5363 10.1074/jbc.M707054200
75. Whittaker, J., Garcia, P., Yu, G. Q., and Mynarcik, D. C. (1994) Transmembrane domain interactions are necessary for negative cooperativity of the insulin receptor Mol. Endocrinol. 8, 1521-1527 10.1210/mend.8.11.7877620
76. Munshi, S., Kornienko, M., Hall, D. L., Reid, J. C., Waxman, L., Stirdivant, S. M., Darke, P. L., and Kuo, L. C. (2002) Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity J. Biol. Chem. 277, 38797-38802 10.1074/jbc.M205580200
77. Munshi, S., Hall, D. L., Kornienko, M., Darke, P. L., and Kuo, L. C. (2003) Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution Acta Crystallogr., Sect. D: Biol. Crystallogr. 59, 1725-1730 10.1107/S0907444903015415
78. Favelyukis, S., Till, J. H., Hubbard, S. R., and Miller, W. T. (2001) Structure and autoregulation of the insulin-like growth factor 1 receptor kinase Nat. Struct. Biol. 8, 1058-1063 10.1038/nsb721
79. Deyev, I. E., Sohet, F., Vassilenko, K. P., Serova, O. V., Popova, N. V., Zozulya, S. A., Burova, E. B., Houillier, P., Rzhevsky, D. I., Berchatova, A. A., Murashev, A. N., Chugunov, A. O., Efremov, R. G., Nikolsky, N. N., Bertelli, E., Eladari, D., and Petrenko, A. G. (2011) Insulin receptor-related receptor as an extracellular alkali sensor Cell Metab. 13, 679-689 10.1016/j.cmet.2011.03.022
80. Popova, N. V., Deyev, I. E., and Petrenko, A. G. (2013) Analysis of structural determinants of alkali sensor IRR positive cooperativity Dokl. Biochem. Biophys. 450, 160-163 10.1134/S1607672913030113
81. Deyev, I. E., Mitrofanova, A. V., Zhevlenev, E. S., Radionov, N., Berchatova, A. A., Popova, N. V., Serova, O. V., and Petrenko, A. G. (2013) Structural determinants of the insulin receptor-related receptor activation by alkali J. Biol. Chem. 288, 33884-33893 10.1074/jbc.M113.483172
82. Deyev, I. E., Popova, N. V., and Petrenko, A. G. (2015) Determination of alkali-sensing parts of the insulin receptor-related receptor using the bioinformatic approach Acta Naturae 7, 80-86
83. Deyev, I. E., Chachina, N. A., Shayahmetova, D. M., Serova, O. V., and Petrenko, A. G. (2015) Mapping of alkali-sensing sites of the insulin receptor-related receptor. The role of L2 and fibronectin domains Biochimie 111, 1-9 10.1016/j.biochi.2014.12.014
84. Tatulian, S. A. (2013) Structural characterization of membrane proteins and peptides by FTIR and ATR-FTIR spectroscopy Methods Mol. Biol. 974, 177-218 10.1007/978-1-62703-275-9-9
85. 2 from studies on native and chimeric proteins J. Biol. Chem. 280, 36773-36783 10.1074/jbc.M506789200
86. Tatulian, S. A. (2010) Structural analysis of proteins by isotope-edited FTIR spectroscopy Spectroscopy 24, 37-43 10.1155/2010/634831
87. 2+-ATPase Biochemistry 41, 741-751 10.1021/bi011148d
88. Tatulian, S. A., Qin, S., Pande, A. H., and He, X. (2005) Positioning membrane proteins by novel protein engineering and biophysical approaches J. Mol. Biol. 351, 939-947 10.1016/j.jmb.2005.06.080
89. Deeks, E. D., Cook, J. P., Day, P. J., Smith, D. C., Roberts, L. M., and Lord, J. M. (2002) The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol Biochemistry 41, 3405-3413 10.1021/bi011580v
90. Uchida, T., Pappenheimer, A. M., Jr., and Harper, A. A. (1972) Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins Science 175, 901-903 10.1126/science.175.4024.901
91. Safavi, M., Foroumadi, A., and Abdollahi, M. (2013) The importance of synthetic drugs for type 2 diabetes drug discovery Expert Opin. Drug Discovery 8, 1339-1363 10.1517/17460441.2013.837883